GDF15 and non-small cell lung carcinoma: We used an orthogonal GDF15-specific serological assay, demonstrating that circulating GDF15 levels correlated significantly with loss of SAT, VAT, SKM and body weight, suggesting a cachexia-mediating role for GDF15 in patients with NSCLC.